PRESS RELEASE published on 10/30/2024 at 19:00, 1 year 4 months ago Informations privilégiées / Communiqué sur comptes, résultats Theraclion annonce ses résultats financiers du premier semestre 2024, avec des avancées majeures sur ses priorités de 2023-2024. Les études pour l'accès au marché américain et le développement produit SONOVEIN® sont au cœur de sa stratégie Résultats Financiers Marché Américain Theraclion SONOVEIN Développement Produit
BRIEF published on 09/06/2024 at 18:35, 1 year 6 months ago Theraclion presents its achievements for the first half of 2024 FDA China R&D Theraclion SONOVEIN®
BRIEF published on 09/06/2024 at 18:35, 1 year 6 months ago Theraclion présente ses réalisations du premier semestre 2024 FDA R&D Chine Theraclion SONOVEIN®
PRESS RELEASE published on 09/06/2024 at 18:30, 1 year 6 months ago Inside Information / Other news releases Theraclion reports strong mid-year achievements focusing on U.S. market access, R&D progress, and Chinese market entry. Key milestones include FDA pivotal study completion and international scientific recognition FDA China R&D Theraclion Achievements
PRESS RELEASE published on 09/06/2024 at 18:30, 1 year 6 months ago Informations privilégiées / Autres communiqués Theraclion confirme ses réalisations du premier semestre 2024, incluant l'étude pivot de la FDA, progrès en R&D et marché chinois FDA R&D Chine Theraclion SONOVEIN®
Published on 03/23/2026 at 14:05, 2 hours 38 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 2 hours 43 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 3 hours 38 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 4 hours 11 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 4 hours 13 minutes ago Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 15:05, 1 hour 38 minutes ago Heidrick & Struggles Launches Heidrick Immersive, an AI-Enhanced Platform for Observing Leadership in Motion
Published on 03/23/2026 at 14:41, 2 hours 1 minute ago CEWE increases dividend for 17 consecutive years
Published on 03/23/2026 at 14:30, 2 hours 13 minutes ago Solvias Earns EcoVadis Bronze Medal, Ranking in Top 35% of Companies for Sustainability Performance
Published on 03/23/2026 at 14:30, 2 hours 13 minutes ago Belvilla Expands in Germany with Hambachtal Holiday Park in Oberhambach
Published on 03/23/2026 at 08:10, 8 hours 33 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 21 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 21 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 22 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 22 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
